SURgical Outcomes in COvid Patients - the SUROCO Multicenter Cohort Study (COVID-19)

NCT04458337 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 318

Last updated 2022-07-12

No results posted yet for this study

Summary

Overall mortality of COVID-19 is variable and has been reported to be between less than 1% and 7%. Many authors around the world also reported data on hospitalization rate, need for intensive care unit (ICU) care and need for mechanical ventilation in SARS-CoV-2 infected patients. To provide anesthetic and surgical care to SARS-CoV-2 infected patients, many health workers have to organize surgical platforms, personal protections and in-hospital trajectories to prevent dissemination and cross-contamination. However, no data has been published on the surgical need of these patients, their postoperative outcomes and the impact they may have on the operating room.

Postoperative outcomes in SARS-CoV-2 infected patients seem to be variable. Expected benefits from a surgical procedure may be different in this population if their postoperative mortality is higher than expected. The association between preoperative characteristics and postoperative outcomes in this population has to be better defined.

There is a need to better quantify these and better inform use of surgical resources during a pandemic. To address this knowledge gap, the investigators propose to conduct a multicenter observational cohort study in SARS-CoV-2 infected patients undergoing a surgical procedure, as well as in those who have recovered from COVID-19.

Conditions

  • Covid-19
  • SARS-CoV2
  • Surgery
  • Surgical Procedure; Complications, Late Effect of Complications
  • Postoperative Complications

Sponsors & Collaborators

  • Maisonneuve-Rosemont Hospital

    collaborator OTHER
  • Centre de recherche du Centre hospitalier universitaire de Sherbrooke

    collaborator OTHER
  • Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal

    collaborator OTHER
  • St. Justine's Hospital

    collaborator OTHER
  • Institut de Cardiologie de Montréal

    collaborator UNKNOWN
  • McGill University Health Centre/Research Institute of the McGill University Health Centre

    collaborator OTHER
  • CHU de Quebec-Universite Laval

    collaborator OTHER
  • Institut universitaire de cardiologie et de pneumologie de Québec, University Laval

    collaborator OTHER
  • Centre hospitalier de l'Université de Montréal (CHUM)

    lead OTHER

Principal Investigators

  • François-Martin Carrier, MD, FRCPC · Centre hospitalier de l'Université de Montréal (CHUM)

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-13
Primary Completion
2022-03-13
Completion
2022-04-13

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04458337 on ClinicalTrials.gov